Rabies Vaccine(Tianjin Genstar Biotech)

To study the immunogenicity and safety of freeze-dried human rabies vaccine (serum-free Vero cells). To prove that 14 days after the first dose, the antibody conversion rate and antibody geometric mean (GMC) of the pre-immunization negative population in the experimental group were non-inferior to those in the control group. 14 days after the full course of immunization, the antibody positivity rate of the pre-immunization negative population in the experimental group was non-inferior to that of the control group. To evaluate the safety of the experimental population inoculated with the test vaccine in a 5-dose immunization schedule.